ArticleIndian journal of thoracic and cardiovascular surgery2022
Myxofibrosarcoma or myxoma: malignant transformation or misdiagnosis.
Article in Indian journal of thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 6 citations in OpenAlex.
- When Recurrent Myxoma Is Not a Myxoma: Reclassification and Recurrence in Cardiac Myxofibrosarcoma.JACC. Case reports · 2026Article
- Staged Cesarean and Cardiac Surgery for Recurrent Left Atrial Myxofibrosarcoma in Pregnancy.JACC. Case reports · 2026Article
- Early recurrence of left atrial myxofibrosarcoma: A case report of a clinical and histopathologic challenge.Journal of cardiothoracic surgery · 2026Article
- Primary Cardiac Myxofibrosarcoma: A Case Report.Surgical case reports · 2025Article
- A rare presentation of primary cardiac myxofibrosarcoma: Case report and literature review.Cancer reports (Hoboken, N.J.) · 2024Review
- Cardiac myxofibrosarcoma: the diagnostic dilemma.Indian journal of thoracic and cardiovascular surgery · 2022Article
- Myxofibrosarcoma or myxoma: malignant transformation or misdiagnosis.Indian journal of thoracic and cardiovascular surgery · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inadequate excision, seeding, multicentricity and malignancy are often ascribed for recurrence of atrial myxomas. Differentiation between benign myxomas and malignant myxofibrosarcomas can be challenging, and a high index of clinical suspicion and vimentin staining on immunohistochemistry is needed to confirm the diagnosis. Early recurrence is common in these patients and completeness of excision is the key. Prognosis despite successful excision is poor. We report a benign atrial myxoma in a young female patient which upon recurrence turned out to be a myxofibrosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.